ScholarWorks@SOONCHUNHYANG UNIVERSITY: Won, Jong Ho

Detailed Information

Won, Jong Ho (원종호)

College of Medicine (Department of Internal Medicine)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Diffuse large Bcell lymphoma:4||Aplastic anemia:4||Survival:3||Prognosis:3||Allogeneic hematopoietic stem cell transplantation:3||Multiple myeloma:3||Rituximab:3||Lymphoma:2||Epidemiology:2||normal karyotype:2||Incidence:2||Induction:2||prognosis:2||Matched related donor:2||Azacitidine:2||Polycythemia vera:2||Thrombocythemia, essential:2||Practice guideline:2||Hematopoietic stem cell transplantation:2||stem cells:2||Primary myelofibrosis:2||diffuse large Bcell lymphoma:2||Radiotherapy:2||Acute myeloid leukemia:2||acute lymphoblastic leukemia:2||acute myeloid leukemia:2||Sinusoidal obstruction syndrome:2||Myeloproliferative disorder:2||Allogeneic stem cell transplantation:2||Chemotherapy:2||Donor cell leukemia:1||Drug therapy:1||Drugrelated side effects and adverse reactions:1||Elderly:1||Elderly AML:1||Epigenetic modification:1||Erectile dysfunction:1||Etoposide:1||Extranodal NK/T cell lymphoma:1||Extranodal NK/Tcell lymphoma:1||Fludarabinea:1||Gastrointestinal tract:1||Ghrelin:1||Graftversushost disease:1||Hepatic venoocclusive disease:1||Hodgkin's lymphoma:1||Human herpesvirus 8:1||Human immunodeficiency virus:1||HyperCVAD:1||IPSS:1||Immunophenotype:1||Interferon alpha:1||Interstitial lung diseases:1||Janus kinase 2V617F:1||Korean:1||LAsparaginase:1||Leptin:1||Lung injury:1||Lymphoblastic lymphoma:1||MG 132:1||Magnetic resonance imaging:1||Mantle cell lymphoma:1||Matched unrelated donor:1||Mesenchymal stem cell transplantation:1||Methylprednisolone:1||Molecular targeted therapy:1||Myelodysplastic syndrome:1||Myeloproliferative neoplasm:1||Nanoparticles:1||Neoplasm metastasis:1||NonHodgkin’s lymphoma:1||Oxaliplatin:1||Pegfilgrastim:1||Peripheral blood stem cell transplantation:1||Philadelphia chromosome:1||Philadelphianegative:1||Primary effusion lymphoma:1||Prophylaxis:1||Radiosurgery:1||Refractory:1||S1:1||Soft tissue sarcoma:1||Spinal metastases:1||Stem cell Transplantation:1||Stem cell transplantation:1||Stereotactic body radiotherapy:1||Stomach neoplasms:1||TDI:1||TET2:1||TNFrelated apoptosisinducing ligand:1||Thalidomide:1||Therapy:1||Thromboembolism:1||Total body irradiation:1||Treatment outcome:1||Trend:1||Unrelated donor:1||Venoocclusive disease:1||Venous thromboembolism:1||WPSS:1||WT1:1||World Health Organization criteria:1||allogeneic stem cell transplant:1||allogeneic stem cell transplantation:1||asthma:1||autologous stem cell transplantation:1||bortezomib:1||breast:1||cKIT:1||central nervous system:1||chronic GVHD:1||chronic graftversushost disease:1||chronic myeloid leukemia:1||cisplatin:1||clinical response:1||collagen:1||conditioning:1||cord blood transplantation:1||de novo leukemic variant:1||dysbiosis:1||elderly:1||follicular lymphoma:1||gemcitabinerefractory:1||genomic classification:1||gut microbiome:1||histopathology:1||homozygous mutation:1||imatinib:1||imatinib trough concentration:1||intestine:1||irondeficiency anemia (IDA):1||mantle cell lymphoma:1||myeloproliferative neoplasms:1||next generation sequencing:1||nextgeneration sequencing (NGS):1||nonHodgkin lymphoma:1||pancreatic cancer:1||phase II trial:1||quality of life:1||radioimmunotherapy:1||refractory:1||rituximab:1||rituximab consolidation:1||side population:1||steroid:1||young women:1||다발골수종:1||림프종:1||.:1||무수혈:1||131Irituximab:1||16S rRNA genebased metagenomics:1||ABCG:1||AML:1||Acute lymphoblastic leukemia:1||Acute promyelocytic leukemia:1||Adiponectin:1||Adult:1||Advanced pancreatic cancer:1||Airway remodeling:1||Alternative donor:1||Apoptosis:1||Autologous stem cell transplantation:1||B cell homeostasis:1||Bloodless treatment:1||Body cavitybased lymphoma:1||Bone marrow:1||Busulfan:1||CHOP regimen:1||Cachexia:1||Calreticulin:1||Central nervous system:1||Clinical outcomes:1||Consolidation:1||Core binding factor:1||Cytarabine:1||Cytogenetics:1||Cytokines:1||Daunorubicin:1||

STATISTICS: Total View :1,229,570; Today View :383

RSS_1.0 RSS_2.0 ATOM_1.0

(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE